Evidence map›Paper›PMID 30659259›Full record

ArticleEuropean journal of human genetics : EJHG2019

Genetic basis for plasma amino acid concentrations based on absolute quantification: a genome-wide association study in the Japanese population.

Akira Imaizumi, Yusuke Adachi, Takahisa Kawaguchi, Koichiro Higasa, Yasuharu Tabara, Kazuhiro Sonomura, Taka-Aki Sato, Meiko Takahashi, Toshimi Mizukoshi, Hiro-O Yoshida and 9 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. The association of genetically determined serum glycine with cardiovascular risk in East Asians.Nutrition, metabolism, and cardiovascular diseases : NMCD · 2021
    Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Akira ImaizumiInstitute for Innovation, Ajinomoto Co., Inc., Kawasaki, Kanagawa, 210-8681, Japan. akira_imaizumi@ajinomoto.com.ORCID 0000-0002-8615-1007
Yusuke AdachiInstitute for Innovation, Ajinomoto Co., Inc., Kawasaki, Kanagawa, 210-8681, Japan.
Takahisa KawaguchiCenter for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, 606-8507, Japan.
Koichiro HigasaCenter for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, 606-8507, Japan.
Yasuharu TabaraCenter for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, 606-8507, Japan.
Kazuhiro SonomuraCenter for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, 606-8507, Japan.
Taka-Aki SatoLife Science Laboratories, Shimadzu Corporation, Seika, Kyoto, 619-0237, Japan.
Meiko TakahashiCenter for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, 606-8507, Japan.
Toshimi MizukoshiInstitute for Innovation, Ajinomoto Co., Inc., Kawasaki, Kanagawa, 210-8681, Japan.
Hiro-O YoshidaInstitute for Innovation, Ajinomoto Co., Inc., Kawasaki, Kanagawa, 210-8681, Japan.
Naoko KageyamaInstitute for Innovation, Ajinomoto Co., Inc., Kawasaki, Kanagawa, 210-8681, Japan.
Chisato OkamotoInstitute for Innovation, Ajinomoto Co., Inc., Kawasaki, Kanagawa, 210-8681, Japan.
Mariko TakasuInstitute for Innovation, Ajinomoto Co., Inc., Kawasaki, Kanagawa, 210-8681, Japan.
Maiko MoriInstitute for Innovation, Ajinomoto Co., Inc., Kawasaki, Kanagawa, 210-8681, Japan.
Yasushi NoguchiInstitute for Innovation, Ajinomoto Co., Inc., Kawasaki, Kanagawa, 210-8681, Japan.
Nobuhisa ShimbaR&D Planning Dept., Ajinomoto Co., Inc, Tokyo, 104-8315, Japan.
Hiroshi MiyanoInstitute for Innovation, Ajinomoto Co., Inc., Kawasaki, Kanagawa, 210-8681, Japan.
Ryo YamadaCenter for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, 606-8507, Japan.
Fumihiko MatsudaCenter for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, 606-8507, Japan. fumi@genome.med.kyoto-u.ac.jp.
Ajinomoto (Japan) · JPKyoto University · JPKansai Medical University · JPShimadzu (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess the use of plasma free amino acids (PFAAs) as biomarkers for metabolic disorders, it is essential to identify genetic factors that influence PFAA concentrations. PFAA concentrations were absolutely quantified by liquid chromatography-mass spectrometry using plasma samples from 1338 Japanese individuals, and genome-wide quantitative trait locus (QTL) analysis was performed for the concentrations of 21 PFAAs. We next conducted a conditional QTL analysis using the concentration of each PFAA adjusted by the other 20 PFAAs as covariates to elucidate genetic determinants that influence PFAA concentrations. We identified eight genes that showed a significant association with PFAA concentrations, of which two, SLC7A2 and PKD1L2, were identified. SLC7A2 was associated with the plasma levels of arginine and ornithine, and PKD1L2 with the level of glycine. The significant associations of these two genes were revealed in the conditional QTL analysis, but a significant association between serine and the CPS1 gene disappeared when glycine was used as a covariate. We demonstrated that conditional QTL analysis is useful for determining the metabolic pathways predominantly used for PFAA metabolism. Our findings will help elucidate the physiological roles of genetic components that control the metabolism of amino acids.

Indexed as

Genome-Wide Association StudyMetabolomicsAdultAmino AcidsBiomarkersFemaleGenome, HumanHumansJapanMaleMiddle AgedPolymorphism, Single NucleotideAmino AcidsBiomarkers

Identifiers

PMID30659259
PMCPMC6460579
OpenAlexW2908594965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.